Dr. Elshimali is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
18751 Tuba Street
Olive View Ucla Med Ctr
Northridge, CA 91324Phone+1 818-515-7618
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pathology-Anatomic and Clinical, 2000 - 2001
- VA Greater Los Angeles Healthcare SystemResidency, Pathology-Anatomic and Clinical, 1996 - 2000
- Texas Tech University Health Sciences Center at LubbockResidency, Pathology-Anatomic and Clinical, 1995 - 1996
- Flushing Hospital Medical CenterInternship, Transitional Year, 1994 - 1995
- Damascus University Faculty of MedicineClass of 1986, MD
Certifications & Licensure
- CA State Medical License 1995 - 2025
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer.Ann M Chan, Brian Aguirre, Lucia Liu, Vei Mah, Justin M Balko
Cancers. 2024-04-12 - Optimization of tissue microarray technique for breast cancer patients: a short communication.Rim M Harfouch, Zuheir Al-Shehabi, Remal Asaad, Majd Aljamali, Rana Issa
Annals of Medicine and Surgery. 2023-10-01 - 12 citationsComp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA.Qiongyu Hao, Piwen Wang, Pranabananda Dutta, Seyung Chung, Qun Li
Cell Death & Disease. 2020-12-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: